Screening for cervical cancer in the era of the HPV vaccine--the urgent need for both new screening guidelines and new biomarkers

MeSH terms

• Age Factors
• Alphapapillomavirus / genetics
• Alphapapillomavirus / isolation & purification*
• Biomarkers, Tumor / metabolism*
• Cost-Benefit Analysis
• DNA, Viral / isolation & purification
• Female
• Humans
• Mass Screening / economics*
• Mass Screening / methods*
• Mass Screening / standards
• Models, Econometric
• Papillomavirus Vaccines* / administration & dosage
• Practice Guidelines as Topic
• United States
• Uterine Cervical Neoplasms / economics
• Uterine Cervical Neoplasms / prevention & control*
• Uterine Cervical Neoplasms / virology